Catherine A. Sohn, Director of Altimmune ALT, has filed 2 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $1.1M. The latest trade was on 05/01.

CS

CS

Catherine A. Sohn

Director

Company

Altimmune ALT

First filing

23/03/27

Trades

21 trades

Buys / sales

2 / 3

12-month net buying

−$1.1M

Last trade

05/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Maze TherapeuticsMAZE	Open-market sale	01/06–01/07	01/08	29,413 sh2 trades	$39.07avg.	$1,149,120.86	−100.0%
AltimmuneALT	Open-market buy	01/05	01/05	500 sh	$4.24	$2,120	+50.0%
AltimmuneALT	Open-market buy	25/03/17	25/03/18	1,000 sh	$5.78	$5,780	No record
Jazz PharmaceuticalsJAZZ	Open-market sale	23/08/14	23/08/15	1,241 sh	$138.16	$171,456.56	−7.7%